Hanimune Therapeutics Patents – Insights & Stats (Updated 2023)

Hanimune Therapeutics has a total of 9 patents globally, out of which 4 have been granted. Of these 9 patents, more than 55% patents are active. The United States of America is where Hanimune Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Hanimune Therapeutics.

Hanimune Therapeutics was founded in 2018. Hanimune Therapeutics is a biotechnology company dedicated to addressing and mitigating food allergies through the application of natural solutions.

Do read about some of the most popular patents of Hanimune Therapeutics which have been covered by us in this article and also you can find Hanimune Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hanimune Therapeutics patent portfolio.

How many patents does Hanimune Therapeutics have?

Hanimune Therapeutics has a total of 9 patents globally. These patents belong to 5 unique patent families. Out of 9 patents, 5 patents are active.

How Many Patents did Hanimune Therapeutics File Every Year?

Hanimune Therapeutics Patent Portfolio

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantHanimune Therapeutics Applications FiledHanimune Therapeutics Patents Granted
20231
20222
202142
20202
20192

How many Hanimune Therapeutics patents are Alive/Dead?

Worldwide Patents

Hanimune Therapeutics Patent Portfolio

How Many Patents did Hanimune Therapeutics File in Different Countries?

The company Hanimune Therapeutics filled all there patents in United States of America.

Where are Research Centers of Hanimune Therapeutics Patents Located?

The Research Centers of HanimuneTherapeutics Patents is the United States of America.

List of Hanimune Therapeutics patents

Hanimune Therapeutics PatentsTitle
US11439173B1Low Allergenicity Well Cooked Food Powder
US11324247B2Food Products For Infants And Babies And Method Of Making Same
US11154081B1Well Cooked Egg Powder
US11154082B2Egg Product For Infants And Babies And Method Of Making Same
WO2023164119A3Compositions And Methods For Food Allergy Prevention
US20220295843A1Low Allergenicity Well Cooked Food Powder
US20200236982A1Tree Nut Powder Formulation
WO2020251644A1Egg Powder
WO2020159732A1Tree Nut Powder Formulation

What are Hanimune Therapeutics key innovation segments?

What Technologies are Covered by Hanimune Therapeutics?

The chart below distributes patents filed by Hanimune Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Hanimune Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Hanimune Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Hanimune Therapeutics?

Related Articles

Schock Patents – Insights & Stats (Updated 2024)

Schock has a total of 395 patents globally, out of which 241 have been granted. Of these 395 patents, more than 62% patents are active. Germany is where Schock has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Germany seems to be the main focused

Read More »

Normet Patents – Insights & Stats (Updated 2024)

Normet has a total of 164 patents globally, out of which 121 have been granted. Of these 164 patents, more than 87% patents are active. Europe (EPO) is where Normet has filed the maximum number of patents, followed by Australia and Canada. Parallelly, Finland seems to be the main focused

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.